Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus protease inhibitors: current progress and future challenges.

C Steinkühler1, U Koch, F Narjes

  • 1Department of Biochemistry, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Via Pontina Km 30,600, 00040 Pomezia, Italy. Christian_Steinkuhler@Merck.com

Current Medicinal Chemistry
|May 29, 2001
PubMed
Summary

Hepatitis C virus (HCV) relies on its NS3 protease, activated by NS4A, for replication. Inhibiting this NS3/4A serine protease is a key strategy for developing new antiviral treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Medical Review Sites - Helpful Hints and Tricks].

Pneumologie (Stuttgart, Germany)·2020
Same author

[Medical Review Sites - Helpful Hints and Tricks].

Laryngo- rhino- otologie·2019
Same author

Correlation between electrical direct current resistivity and plasmonic properties of CMOS compatible titanium nitride thin films.

Optics express·2018
Same author

Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany.

Bone marrow transplantation·2017
Same author

One in two cancer patients is significantly distressed: Prevalence and indicators of distress.

Psycho-oncology·2017
Same author

[Rehabilitation Processes in Out- and Inpatient Rehabilitation after Radical Prostatectomy].

Die Rehabilitation·2017

Area of Science:

  • Virology
  • Biochemistry
  • Medicinal Chemistry

Background:

  • Hepatitis C is a chronic viral infection impacting 1-3% globally.
  • Hepatitis C virus (HCV) uses a polyprotein precursor for replication.
  • Proteolytic processing of the viral polyprotein is essential for viral assembly.

Purpose of the Study:

  • To review recent advancements in understanding the structure and function of the NS3/4A serine protease.
  • To discuss the development of selective and potent NS3 protease inhibitors for antiviral therapy.

Main Methods:

  • Review of recent scientific literature on HCV NS3 protease.
  • Analysis of structural and functional data of the NS3/4A enzyme complex.
  • Examination of medicinal chemistry efforts targeting NS3 protease inhibitors.

Related Experiment Videos

Main Results:

  • The NS3 protein contains a chymotrypsin-like serine protease domain.
  • NS3 protease requires the cofactor NS4A for full activation, forming a heterodimeric enzyme.
  • Significant progress has been made in developing selective and potent NS3 protease inhibitors.

Conclusions:

  • The NS3/4A serine protease is a critical target for HCV antiviral drug development.
  • Understanding the enzyme's structure and function is crucial for designing effective inhibitors.
  • Ongoing research focuses on creating potent and selective inhibitors to combat Hepatitis C.